Gilteritinib: An FMS-like tyrosine kinase 3/AXL tyrosine kinase inhibitor for the treatment of relapsed or refractory acute myeloid leukemia patients.
2020
Acute myeloid leukemia has recently undergone a significant transition into identifying and successfully inhibiting driver mutations leading to disease. One of the most common mutations in acute my...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
59
References
0
Citations
NaN
KQI